<verdict>MOSTLY REALISTIC</verdict>
<score>8</score>
<reasoning>
All six action rolls and all five threat rolls were applied correctly. Action 1 (73 vs 40) succeeded, Actions 2, 5 and 6 (23<45, 04<35, 26<30) failed, and Actions 3 and 4 were narrow partials (47≥45, 45≥40). Four threats materialised (14<20, 03<20, 14<15, 10<20) and Threat 5 did not (57≥20). The simulator's reasons for lowering the adversary's likelihoods were sensible. Apollo testing only public models instead of the unreleased successor, and a single appellate ruling being rare in any given month, are both well argued. Materialised threats were kept proportionate: the v3 evasion stayed in trade press with no field miss, and practitioners credited the up-front disclosure. That is how security communities actually react. Bio pacing is believable, with acceptable PK, a weaker lung-model result explained by penetration, a slipped preprint and MC-7 dropped under the player's own go/no-go. Institutional texture is strong: counsel treating the "publish bad scores" pledge as a forward-looking disclosure, ODJFS staff escalating instead of deciding, and DSIT refusing to adopt a single developer's text. The main weaknesses are some double-counting between action failures and overlapping threats, a slightly high failure probability on routine actions, and a hospital upgrade pace that is a little fast.
</reasoning>
<issues>
- Action 5's P(failure) of 35% is high for mostly routine steps. Delivering the extract, publishing figures and asking programme staff a question all run through existing channels. The one genuinely uncertain step was the MOU signature, and it should have been priced on its own.
- Double-counting between actions and threats:
  - Action 6's failure and Threat 4 both produce the DSIT slip.
  - Action 2's failure and the counsel ruling (part of Threat 2's premise) overlap.
  - The simulator even said the ring-fence slip was "priced into Action 2," but then described the counsel ruling as a consequence anyway.
- The combined effect of Action 6's failure and Threat 4 pushed finalisation from mid-year all the way to September. That is a large slip from one month's consultation responses; July or August would be more typical.
- "Four of five live sites upgraded within ten days" is fast for hospital change-control, even with a one-click path.
- DeepSeek V5-Lite reaching "near-GPT-6 on coding at a fraction of the size" is a notable exogenous capability jump. It is plausible, but no reasoning about its size was given.
</issues>
<feedback_for_simulator>
- When a threat materialises on the same axis as a failed action, apply the downside once, or state explicitly what the threat adds beyond the failure.
- Split multi-part actions: give low P(failure) to the routine sub-steps and price the externally controlled steps (MOU signatures, regulator timing) separately.
- Keep physical and institutional rollout realistic. Hospital upgrades usually take weeks of change-control, so expect some sites to lag into June.
- Carry forward the Ohio cap (likely hit in June or July) and the Apollo narrative. Model how Anthropic's silence during the quiet period affects the June 30 bio-floor review and the IPO timeline.
</feedback_for_simulator>
